Lifeward (NASDAQ:LFWD) Trading Down 3.4% – Time to Sell?

Lifeward Ltd. (NASDAQ:LFWD) shares dropped 3.4% during trading on Thursday . The stock traded as low as $6.69 and last traded at $6.76. Approximately 5,008 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 7,272 shares. The stock had previously closed at $7.00.

Analyst Ratings Changes

LFWD has been the topic of several research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a research report on Tuesday, April 21st. HC Wainwright boosted their price objective on shares of Lifeward to $10.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $10.00.

Lifeward Price Performance

The stock’s 50-day moving average price is $6.76 and its 200 day moving average price is $7.12. The firm has a market cap of $10.34 million, a P/E ratio of -0.37 and a beta of 0.32.

Lifeward (NASDAQ:LFWD) last announced its quarterly earnings data on Thursday, March 19th. The company reported ($3.60) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($3.53). The business had revenue of $5.08 million during the quarter, compared to the consensus estimate of $7.87 million. Lifeward had a negative return on equity of 145.55% and a negative net margin of 90.38%. As a group, analysts forecast that Lifeward Ltd. will post -1.14 EPS for the current fiscal year.

Institutional Trading of Lifeward

A number of institutional investors have recently made changes to their positions in LFWD. Citadel Advisors LLC lifted its position in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after purchasing an additional 198,406 shares in the last quarter. HRT Financial LP lifted its position in shares of Lifeward by 149.7% in the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after purchasing an additional 29,423 shares in the last quarter. Jane Street Group LLC raised its position in Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after acquiring an additional 29,927 shares in the last quarter. Finally, Virtu Financial LLC raised its position in Lifeward by 158.0% during the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares in the last quarter. Institutional investors own 26.76% of the company’s stock.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.